关键词：仿制药；专利品牌药；效能；管理；质量；用途
摘 要：Generic drugs are copies of patented brand name drugs that have identical dosage form, potency, route of administration, quality, and intended use. These drugs contain the same active ingredients as the original brand name drugs. They are available once the patent protections given to the original developers have expired and generally cost 50-70 percent less than their brand name counterparts. However, they meet the same standards for safety, quality, and effectiveness as innovator drugs because the manufacturers typically do not have additional expenses for developing and marketing a new drug. When a patent expires, manufacturers can apply for FDA approval to produce and sell generic versions of the drug. For the approval of generics, which requi marketing authorization and are exact or close copies of already approved drugs, manufacturers are required to apply for an ANDA approval .
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Category

07.1 Global Generic Drugs Market Segmentation by

Category

07.2 Global Biosimilars Market

07.2.1 Market Size and Forecast

08. Market Segmentation by Therapeutic

Application

08.1 Global Generic Drugs Market Segmentation by

Therapeutic Application

09. Geographical Segmentation

09.1 Global Generic Drugs Market by Geographical

Segmentation

09.2 Generic Drugs Market in the Americas

09.2.1 Market Size and Forecast

09.3 Generic Drugs Market in the US

09.3.1 Market Size and Forecast

09.4 Generic Drugs Market in the EMEA Region

09.4.1 Market Size and Forecast

09.5 Generic Drugs Market in Europe

09.5.1 Market Size and Forecast

09.6 Generic Drugs Market in Europe by Country

09.6.1 Generic Drugs Market in Germany

09.6.2 Generic Drugs Market in the UK

09.6.3 Generic Drugs Market in Italy

09.6.4 Generic Drugs Market in France

09.6.5 Generic Drugs Market in Spain

09.7 Generic Drugs Market in the APAC Region

09.7.1 Market Size and Forecast

09.7.2 Generic Drugs Market in China

09.7.3 Generic Drugs Market in India

09.7.4 Generic Drugs Market in Australia

10. Key Leading Countries

10.1 US

10.2 China

10.3 India

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive Scenario

18.1.1 Key News

18.1.2 Mergers and Acquisitions

18.2 Vendor Analysis 2013

18.3 Other Prominent Vendors

19. Key Vendor Analysis

19.1 Actavis plc

19.1.1 Business Overview

19.1.2 Business Segmentation

19.1.3 Key Information

19.1.4 SWOT Analysis

19.2 Mylan Inc.

19.2.1 Business Overview

19.2.2 Business Segmentation

19.2.3 Key Information

19.2.4 SWOT Analysis

19.3 Novartis International AG

19.3.1 Business Overview

19.3.2 Business Segmentation

19.3.3 Key Information

19.3.4 SWOT Analysis

19.4 STADA Arzneimittel AG

19.4.1 Business Overview

19.4.2 Business Segmentation

19.4.3 Key Information

19.4.4 SWOT Analysis

19.5 Teva Pharmaceutical Industries Ltd.

19.5.1 Business Overview

19.5.2 Business Segmentation

19.5.3 Key Information

19.5.4 SWOT Analysis

20. Other Reports in this Series